Inflammatory responses to dietary and surgical weight loss in male and female mice by Griffin, Cameron et al.
RESEARCH Open Access
Inflammatory responses to dietary and
surgical weight loss in male and female
mice
Cameron Griffin1, Chelsea R. Hutch2, Simin Abrishami1, Daria Stelmak2, Leila Eter1, Ziru Li3, Eric Chang1,
Devyani Agarwal1, Brian Zamarron1, Mita Varghese1, Perla Subbaiah4, Ormond A. MacDougald3,
Darleen A. Sandoval2 and Kanakadurga Singer1,5*
Abstract
Background: Weight loss by surgery or lifestyle changes is strongly recommended for obese individuals to
improve metabolic health, but the underlying impairments that persist from a history of obesity remain unclear.
Recent investigations demonstrate a persistent inflammatory state with weight loss and bariatric surgery, but the
mechanism and impact are not fully understood. Additionally, these studies have not been performed in females
although women are the majority of individuals undergoing weight loss interventions.
Methods: The goal of this study was to determine the sex differences in metabolically induced inflammation after
dietary weight loss (WL) or bariatric surgery. Following a 60% high-fat diet (HFD) for 12 weeks, C57Bl/6j mice
underwent either a dietary switch to normal chow for WL or vertical sleeve gastrectomy (VSG) and were evaluated
8 weeks after intervention. WL effects on myelopoiesis were further evaluated with bone marrow chimeras.
Results: Both sexes had a decrease in adiposity and total weight following WL or VSG intervention. With HFD,
females had very little inflammation and no further increase with WL, but males had persistent inflammation even
after WL despite metabolic improvement. Interestingly, after VSG, myeloid inflammation was increased in the livers
of males and to a lesser extent in females.
Conclusions: These studies demonstrate that regardless of sex, it is critical to assess an individuals’ history of
obesity rather than just rely on current weight status in medical decision-making. There are long-lasting effects on
tissue inflammation in both sexes especially with surgical weight loss. Dietary change is overall most effective to
improve meta-inflammation in obese males on its own or in combination with surgical weight loss.
Keywords: Obesity, Macrophage, Myelopoiesis, Metabolism, Sex-differences, Bariatric surgery
Introduction
Obesity is a significant public health crisis due to the rise
in predominantly metabolic sequelae [1–3]. Many weight
loss interventions have been created to attenuate the med-
ical sequelae of obesity. While there have been pharmaco-
logic treatments [4], the most popular sought-after
interventions include dietary/lifestyle changes and more
recently bariatric surgery [5]. Although a 10–20% reduc-
tion in weight can have significant metabolic improve-
ments with improved glucose and insulin levels [6], effects
on the chronic inflammatory state of obesity have been
less thoroughly examined.
Following high-fat caloric intake, adipose tissue depots
expand leading to obesity. Concurrent with this expansion
is an increase of both resident and recruited tissue macro-
phages in response to adipocyte hypertrophy [7]. An in-
crease in chemokine signals within gonadal white adipose
tissue (GWAT), the main visceral fat depot in animal
models, leads to expansion of recruited macrophages. Spe-
cifically, monocyte chemoattractant protein-1/C-C
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chemokine receptor type 2 (MCP-1/CCR2) signals are
known to recruit Ly6chi monocytes, which differentiate into
CD64+/CD11c+ adipose tissue macrophages (CD11c+
ATMs) [7] and accumulate in crown-like structures (CLS),
around damaged and dying adipocytes [8]. CD11c+ ATMs
are linked to obesity-related sequelae and are functionally
distinct from resident, CD64+CD11c− macrophages
(CD11c− ATMs) [9]. While these CD11c+ macrophages typ-
ically help with maintaining tissue homeostasis [10], the ex-
pansion and detrimental cytokine production leads to a
pathologic state of tissue dysfunction.
Weight loss has become a primary recommendation
for resolution of obesity and obesity-related diseases.
However, recent investigations into the impact of weight
loss in animal models have determined that even with
weight loss, there is an underlying myeloid inflammation
that remains for at least 8 weeks [11]. Similar findings
have been observed in studies using vertical sleeve gas-
trectomy, demonstrating a persistent inflammatory state
post-weight loss [12, 13]. While these are clinically rele-
vant pre-clinical findings, there is a critical gap in the in-
clusion of female animal models in these studies. This is
an important gap to fill given that over 80% of bariatric
surgeries [14, 15] and a majority of dietary and exercise
weight loss programs are predominantly filled with
women [16]. Also, there is some controversy in the results
since some studies have demonstrated improvement in
systemic inflammation with dietary weight loss [17, 18]
and some report no changes at all within adipose tissue
[19, 20]. These contradictory results may be due to the
age, timing of weight loss, and sex differences.
In order to understand if the persistent tissue inflam-
mation and metabolic dysfunction is a critical issue in
men and women after weight loss, we have pursued in-
vestigations in both male and female animal models. We
hypothesized that given the priming of males to
meta-inflammation, persistent inflammation would be
most prominent in male mice than females with obesity
and weight loss regardless of method. Our studies show
that male animals had improved but some persistent
adipose tissue and liver inflammation even after weight
loss while female adipose tissue remained in a low-in-
flammatory state. The programming of this priming for
tissue inflammation persisted after bone marrow trans-
plantation (BMT) in male animals. Surprisingly, with
vertical sleeve gastrectomy, adipose tissue inflammation
due to resident CD11c− macrophages was sustained in
both post-surgical males and females.
Methods
Animals and animal care
Male and female C57Bl/6J mice were purchased from
Jackson Laboratory (Bar Harbor, Maine). Six-week-old
male and female mice were fed either a normal diet
(LabDiet 13.5% fat 5L0D, St. Louis, MO) or high-fat diet
(HFD, Research Diets D12492 60% fat, New Brunswick,
NJ). A subgroup of HFD-induced obese mice was
switched back to ND after 12 weeks of HFD to create
the weight loss (WL) animal model. About 4–8 mice
were used for dietary experiments. Glucose tolerance tests
(GTT) were performed after 6 h of fasting. Mice were
injected with intraperitoneal insulin (0.7 g/kg) and
D-glucose (Gibco, Indianapolis, IN) measured by
Free-Style Lite glucose meter. All mouse procedures were
approved by the University of Michigan Committee on
Use and Care of Animals and were conducted in compli-
ance with the Institute of Laboratory Animal Research
Guide for the Care and Use of Laboratory Animals.
Vertical sleeve gastrectomy surgery
Animals were placed on 12 weeks of HFD starting at 6
weeks of age. Two weeks prior to surgery (after 10 weeks
of HFD), mice were singly housed. Mice were then sepa-
rated into two surgery groups, sham surgery or vertical
sleeve gastrectomy (VSG). After surgery, animals from
the sham group were either continued on 60% high-fat
diet for 8 weeks or switched to control chow. All surger-
ies were performed under isoflurane anesthesia as previ-
ously described [12, 21]. For VSG, the lateral stomach
was resected along the major curvature to form a
remnant tube. A N of 4–8 again was used in sham
groups but a larger N was used in the VSG groups for
experiments (8–12) given complications that could
occur in this group. Sham procedures involved exposure
and manipulation of the stomach. After surgery, mice
were fed a liquid diet Osmolite 1Cal (Abbott Nutrition,
Columbus, OH) for 4 days, then switched into either ND
or HFD for 8 weeks.
Immunofluorescence
Whole-mount adipose tissue explants were fixed over-
night in a 1% paraformaldehyde solution (Electron
Microscopy Sciences, Hatfield, PA) and were used for
immunofluorescence as previously described [8]. Anti-
bodies used for immunofluorescence included Caveolin1
(Polyclonal rabbit-anti-Caveolin, BD Pharmingen, San
Jose, CA), Mac2 (Rat Galectin-3 monoclonal antibody
(M3/38), BD Pharmingen, San Jose, CA), and 4′,6-Dia-
midine-2′-phenylindole dihydrochloride (DAPI) (Roche,
Basel, Swiss). Secondary antibodies included goat
anti-rabbit IgG Alexa Fluor 488 (polyclonal, Invitrogen,
Carlsbad, CA) and goat anti-rat IgG Alexa Fluor 568
(polyclonal, Invitrogen, Carlsbad, CA).
Flow cytometry
Adipose tissue and liver were digested in RPMI 1640
(Gibco, Indianapolis, IN) with 1 mg/ml collagenase
(Clostridiopeptidase A from Clostridium histolyticum
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type II Sigma-Aldrich, St. Louis, MO) as previously de-
scribed [22] on a rocking platform shaker for 25 min at
37 °C. The stromal vascular fraction (SVF) was separated
from adipocytes by centrifugation. The following anti-
bodies were used for flow cytometry: anti-mouse CD45
eFluor 450 (30-F11 monoclonal, Invitrogen, Carlsbad,
CA), anti-mouse CD11c eFluor 780 (N418 monoclonal,
Invitrogen, Carlsbad, CA), anti-mouse CD64 PE (X54-5/
7.1 monoclonal, BD Pharmingen, San Jose, CA), and
anti-mouse Ly6G (Gr1) FITC (IA8, BD Pharmingen, San
Jose, CA). Adipose tissue macrophages are CD64+ and
separated as M2 (CD11c−) or M1 (CD11c+). Dendritic
cells are CD64−CD11c+ cells. Analysis was performed
using a BD Biosciences FACSAria and FlowJo v.10
(Treestar) software.
Statistical analysis
Results are presented as mean ± SEM. The analysis was
first performed to evaluate for any significant main ef-
fects and interactions regarding sex and diet. Compari-
sons were then made with one-way ANOVA using
Tukey’s method followed by a three-factor general linear
model. Table 1 provides the results of general linear
models assessing the significance of the main effects and
interactions for the three factors: sex, surgery, and diet.
Table 2 gives the results of Tukey’s multiple comparisons
by providing adjusted p values.
Results
Males have impaired metabolism with HFD that resolves
in weight loss (WL), while females remain metabolically
intact
Male and female C57Bl/6J mice were placed on ND or
fed a 60% HFD starting at 6 weeks of age. After 12 weeks
of HFD, one group of animals was switched back to a
control chow to mimic dietary WL. After 8 weeks of
normal chow, the body weights of the WL group re-
duced and were similar to the ND animal weights for
both males and females (Fig. 1a, b). After 6 weeks of
WL, all animals were fasted for 6 h and serum glucose
and insulin evaluated. Fasting glucose levels varied by
diet in both sexes and were significantly lower in WL
Table 1 Significance of main effects and interactions (results for VSG experiment)
Variables P values for
Sex (M/F) Surgery (V/S) Diet (C/H) Sex and surgery Sex and diet Surgery and diet Three factors
Size parameters
Weight 0.000 0.000 0.000 0.049 0.000 0.116 0.658
GWAT mass 0.000 0.004 0.000 0.945 0.000 0.141 0.404
IWAT mass 0.000 0.000 0.000 0.049 0.000 0.001 0.063
Liver mass 0.000 0.005 0.000 0.005 0.001 0.010 0.012
Spleen mass 0.045 0.000 0.000 0.067 0.238 0.445 0.262
GWAT Adipocyte size 0.367 0.005 0.000 0.536 0.014 –
GWAT leukocytes
GWAT ATM 0.000 0.466 0.000 0.035 0.034 0.015 0.490
GWAT CD11c+ 0.000 0.000 0.011 0.015 0.154 0.676 0.452
GWAT CD11c− 0.000 0.053 0.000 0.306 0.061 0.002 0.717
GWAT DC 0.682 0.418 0.596 0.043 0.181 0.647 0.608
GWAT PMN 0.387 0.000 0.958 0.201 0.889 0.833 0.886
IWAT leukocytes
IWAT ATM 0.248 0.801 0.000 0.147 0.162 –
IWAT CD11c+ 0.783 0.003 0.000 0.005 0.000 –
IWAT CD11c− 0.201 0.667 0.002 0.308 0.496 –
IWAT DC 0.010 0.008 0.000 0.363 0.051 –
Liver leukocytes
Liver TM 0.315 0.000 0.284 0.918 0.026 0.187 0.325
Liver TM CD11c+ 0.278 0.606 0.000 0.021 0.000 0.858 0.024
Liver TM CD11c− 0.226 0.000 0.600 0.770 0.081 0.168 0.508
Liver DC 0.035 0.004 0.000 0.000 0.000 0.001 0.000
Liver PMN 0.156 0.000 0.816 0.196 0.745 0.579 0.163
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females compared to males (p < 0.001 for diet and sex ef-
fects) (Fig. 1c). Male insulin levels were increased with
HFD, as we have previously shown [11], but female insu-
lin levels did not significantly increase with HFD and
were significantly lower in HFD females (Fig. 1d). After
just 6 weeks, the WL group had significantly lower insu-
lin levels in male mice (Fig. 1d). At 19 weeks of HFD,
glucose tolerance testing was impaired in males. How-
ever, with 7 weeks of diet switch, glucose tolerance im-
proved in male WL animals compared to HFD (Fig. 1e).
Female animals remained glucose tolerant in HFD and
WL states (Fig. 1f ).
As expected, HFD increased body mass and liver mass
in males and weight loss reduced both body weight and
liver weight to that of control animals, as previously
published [23] (Fig. 1g, h). There was a significant sex
effect with female HFD animals having lower weight and
liver mass (Fig. 1g, h). HFD animals had increased
visceral gonadal white adipose tissue (GWAT) and sub-
cutaneous inguinal white adipose tissue (IWAT) depots
in both sexes (Fig. 1i, j). After 8 weeks of diet switch,
WL animals still had heavier GWAT fat pads while
IWAT weights returned to control weights in both sexes
(Fig. 1i, j).
Males have an increased myeloid response to HFD that
persists in WL
To assess potential changes in the degree of inflamma-
tion after a WL intervention, we isolated targeted meta-
bolic tissues and evaluated leukocytes by flow cytometry
in the weight loss mice model. GWAT macrophages ex-
panded in HFD males and did not fully resolve in WL
mice (Fig. 2a). HFD-fed females had no expansion in
GWAT macrophages, and these did not change with diet
switch (Fig. 2a). In males, GWAT ATMs regardless of
CD11c type were increased in HFD and WL, though
Table 2 Comparison of diet groups by gender. Adjusted p values for Tukey’s simultaneous tests. Surgery comparisons are shown in
Figs. 5, 6, 7, and 8 (results for VSG experiment)
Variable Surgery comparisons Diet comparisons Sex comparisons
MSC-
MVC
MSH-
MVH
FSC-
FVC
FSH-
FVH
MSC-
MSH
MVC-
MVH
FSC-
FSH
FVC-
FVH
MSC-
FSC
MSH-
FSH
MVC-
FVC
MVH-
FVH
Size parameters
Weight 0.590 0.000 1.000 0.618 0.000 0.000 0.001 0.101 0.001 0.000 0.572 0.000
GWAT mass 0.979 0.388 1.000 0.081 0.000 0.000 0.000 0.046 0.817 0.000 1.000 1.000
IWAT mass 1.000 0.000 1.000 0.429 0.000 0.000 0.002 0.400 1.000 0.000 1.000 0.000
Liver mass 1.000 0.000 1.000 1.000 0.000 0.890 0.997 0.999 0.306 0.000 0.894 0.052
Spleen mass 0.111 0.000 0.223 0.257 0.252 0.025 0.431 0.780 1.000 1.000 0.999 0.011
Adipocyte size – 0.160 – 0.532 0.000 – 0.053 – 0.979 0.086 – 0.474
GWAT leukocytes
GWAT ATM 1.000 0.010 0.792 1.000 0.000 0.876 0.462 1.000 0.018 0.000 0.907 0.012
GWAT CD11c+ 0.407 0.001 0.995 1.000 0.045 0.924 1.000 0.996 0.001 0.000 0.719 0.033
GWAT CD11c− 0.544 0.762 0.112 1.000 0.000 0.982 0.191 1.000 0.874 0.004 1.000 0.249
GWAT DC 0.917 0.696 0.965 1.000 0.956 0.991 1.000 0.988 0.985 0.577 0.876 1.000
GWAT PMN 0.205 0.005 0.744 0.774 1.000 1.000 1.000 1.000 1.000 1.000 0.981 0.797
IWAT leukocytes
IWAT ATM – 0.850 – 0.941 0.007 – 0.571 – 0.862 0.038 – 0.991
IWAT CD11c+ – 0.003 – 1.000 0.000 – 1.000 – 0.999 0.000 – 0.988
IWAT CD11c− – 0.999 – 0.881 0.064 – 0.446 – 0.725 0.206 – 0.994
IWAT DC – 0.146 – 0.727 0.000 – 0.156 – 0.760 0.001 – 0.237
Liver leukocytes
Liver TM 0.031 0.747 0.194 0.155 0.025 1.000 1.000 0.996 0.935 0.240 1.000 0.909
Liver TM
CD11c+
1.000 0.039 1.000 0.404 0.000 0.316 0.926 0.986 0.132 0.002 0.516 0.960
Liver TM
CD11c−
0.014 0.324 0.124 0.224 0.184 1.000 1.000 0.984 0.991 0.575 1.000 0.799
Liver DC 1.000 0.000 1.000 0.982 0.000 0.177 0.823 0.607 0.788 0.000 0.951 0.999
Liver PMN 0.009 0.298 0.958 0.621 0.996 0.828 1.000 0.999 1.000 0.999 0.279 0.998
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Fig. 1 Males specifically have impaired metabolism with high-fat diet exposure that resolves with weight loss. WT male and female C57Bl/6J mice
were placed on high-fat diet (HFD) starting at 6 weeks of age. After 12 weeks of diet, a group of these mice was switched to normal chow to
mimic dietary weight loss (WL). A control group remained on normal chow the entire time (ND). Weekly weights were recorded in males (a) and
females (b). Metabolic studies included c fasting glucose and d fasting insulin at 6 weeks of WL and glucose tolerance (GTT) testing at 7 weeks of
WL in e males and f females. At 26 weeks of age, animal g weight and tissue weight including h liver, i gonadal white adipose tissue (GWAT),
and j inguinal white adipose tissue (IWAT). Statistics from diet and sex interaction in box*p < 0.05, ****p < 0.001. ###p < 0.005 and ####p < 0.001
for comparisons between sexes of the same diet group. N = 4–8 per group. $ Data previously published [23]
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weight loss did show inflammatory CD11c+ ATM reduc-
tion when compared to HFD animals (Fig. 2a). Dendritic
cells (DCs) were similar amongst all groups in both
sexes (Fig. 2a).
A similar pattern of expansion of ATMs was seen in
male HFD IWAT, but DCs were also expanded and both
myeloid populations reduced with WL (Fig. 2b). ATMs
and DCs in subcutaneous inguinal fat did not significantly
expand in HFD females and were unchanged with weight
loss (Fig. 2b). Tissue macrophages increased within the
liver in males on HFD (Fig. 2c). Within the liver, CD64+
cells increased only marginally in males with HFD but sig-
nificantly so with WL and were mostly the CD11c− type.
CD64−CD11c+ cells increased with HFD in both sexes
and reduced with WL (Fig. 2c). Similar to the fat depots,
WL resolved CD11c+CD64+ cell accumulation in male
livers as well. The resolution in CD11c+ populations is
critical given that this cell population is strongly associ-
ated with antigen presentation and T cell activation. Since
CD11c+ ATMs are thought to be recruited, it is interesting
that this macrophage population completely improved in
IWATand liver, but not in GWAT.
Consistent with our prior studies, myeloid granulocyte
and macrophage precursors (GMPs) increased in males
with HFD but more significantly so in WL [8, 24]
(Fig. 2d). Overall, these results demonstrate that in
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males, myeloid inflammation is only partially improved
with WL in visceral tissues but significantly improved in
liver and IWAT.
Hematopoietic cells transplanted from WL animals are
not primed to impair metabolism
To determine whether hematopoietic stem cell changes
due to obesity or weight loss might contribute to varied
inflammatory responses, we performed bone marrow
transplant experiments. Twenty-six-week-old animals
from ND, HFD, or WL groups were used as bone marrow
donors. Bone marrow was isolated and injected into
8-week-old WT C57Bl/6J irradiated recipient animals. For
these experiments, donor sex was the same as recipient
sex. Animals were allowed to recover from bone marrow
transplantation (BMT), and 6 weeks post-BMT were chal-
lenged to 16 weeks HFD to determine if a subsequent
HFD challenge, second hit, to the bone marrow would
lead to a priming for increased metabolic inflammation.
In males, we have previously observed that with 16 weeks
of HFD, bone marrow transplant and re-challenge leads to
increased glucose impairment over ND recipient BMT an-
imals [8]. Consistent with prior results, males with HFD
donor BM had impaired insulin sensitivity as seen in insu-
lin tolerance test (ITT) (Fig. 3a) and glucose intolerance in
males (Fig. 3b). While not significant, male animals with
WL BM tended to have higher glucoses in response to in-
sulin (ITT) (p = 0.07 ND vs WL).
In contrast, no changes were observed in female groups
regardless of donor group (Fig. 3c). While there were dif-
ferences in glucose homeostasis in males, there was no
significant difference in body weight (Fig. 3d), GWAT
(Fig. 3e), IWAT (Fig. 3f), or liver (Fig. 3g) by donor group.
This suggests that the HFD donor BM impaired glucose
homeostasis independent of body, fat pad, or liver mass.
As expected, weights for all variables were lower in fe-
males than males (sex effect p < 0.001). We further iso-
lated tissues to look at tissue macrophages and found that
there was a near significant diet effect and animals with
male HFD donor marrow had a larger number of ATMs
in GWAT and IWAT (Fig. 4a, b) and more total ATMs
than female mice (sex effect p < 0.001). There were no sig-
nificant differences in GWAT or IWAT ATM type or
DCs, although females still had lower numbers (Fig. 4a, b).
A similar trend was observed in the liver with lower num-
bers of macrophages in females but no differences
amongst diet groups (Fig. 4c). Overall, in female animals,
marrow, regardless of prior exposure, remains protected
from myeloid responsiveness to HFD.
VSG and WL both improve body composition of formerly
HFD fed mice regardless of sex
To understand whether surgically induced weight loss
responses differ from standard diet weight switch,
animals were treated with 12 weeks of HFD and then
underwent sham or VSG surgery. Post-surgery, sham an-
imals were either maintained on HFD or switched to a
standard chow, to mimic WL controls. VSG animals
were standardly maintained on HFD to assess surgery
weight loss effects alone. A small group of VSG animals
was switched to standard chow after surgery to mimic
our prior WL studies. Chow switch in sham and VSG
animals led to improved weight loss compared to VSG
alone (Fig. 5a), with greater improvement in fat mass
loss (Fig. 5b, c) and reduction in adipocyte size changes
(Fig. 5d, e). VSG itself without diet switch led to im-
proved body weight and IWAT weight in males (Fig. 5a,
c), with near significant improvement in GWAT weight
in females (Fig. 5b). However, liver weight increased only
in male HFD-fed animals and resolved in both VSG
treatment groups or chow switch. No effects of liver
weight were observed in either of the female groups
(Fig. 5f ). Overall, while VSG improved body weight,
IWAT, and liver mass, there was an additive effect with
chow switch. Interestingly, splenomegaly occurred in
VSG groups of both sexes but significantly so only in
male HFD groups (Fig. 5g).
VSG and WL both decrease obesity-associated adipose
tissue CD11c+ ATMs in male mice
Flow cytometry analysis of visceral adipose tissue (VAT)
macrophages showed that a chow switch reduced ATMs
and to a greater extent than VSG in males and females
(Fig. 6a). A switch to chow significantly decreased ATMs
when comparing both subtypes (CD11c+ and CD11c−)
(Fig. 6b, c), while VSG decreased mostly CD11c+ ATMs.
DCs were also reduced but not significantly different
with chow switch and VSG in male animals (Fig. 6d).
VSG however increased neutrophils indicated by Ly6G+
cells in adipose tissue in both sexes with lack of signifi-
cant two-factor interaction but significant surgery effect
(p < 0.001) (Table 1 and Fig. 6e). The alteration in
CD11c+ ATM accumulation was seen by persistent CLS
in male animals in sham HFD, with some improvement
with VSG (Fig. 6f ). The CLSs appear more prominent in
this group due to continued adipocyte hypertrophy in
HFD-fed animals while adipocytes were small with the
chow switch (Fig. 6f ). Similar findings were observed in
the IWAT compartment, with greater reduction in
CD11c+ ATMs by chow switch in males only (Fig. 7a, b).
Unlike the GWAT, CD11c− ATMs and DCs did not
show any significant changes in the VSG HFD groups in
male and female IWAT (Fig. 7c, d). To understand if the
female protection from adipose inflammation was due to
estrogen, a subgroup of ovariectomized mice underwent
VSG and was found to have little change in ATM accu-
mulation with no significant change in inflammation
with VSG (Fig. 7e).
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Fig. 3 Male and female hematopoietic cells transplanted from weight loss animals are no longer primed to impair metabolism. ND, HFD, and WL
animals were generated and at 26 weeks of age, bone marrow was injected into irradiated C57Bl6/j mice of the same sex. Six weeks following
bone marrow transplantation, all mice were started on a 60% HFD. a Insulin tolerance tests (ITT) studies were performed in males at 14 weeks of
HFD. GTT studies were performed at 12 weeks of HFD in b males and c females with calculated area under the curve (AUC). After 16 weeks of
HFD, animal d weight and tissue, e GWAT, f IWAT, and g liver were measured. *p < 0.05. #p < 0.05, ##p < 0.01, ### p < 0.005, ####p < 0.001 for
comparisons between sexes of the same diet group. N = 4–10 per group
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VSG resolves pro-inflammatory ATMs in males but
promotes CD11c− TMs numbers in both sexes in liver
VSG is well known to relieve obesity-related hyperlipid-
emia and NAFLD [25]. In addition to steatosis, liver in-
flammation and fibrosis is part of the pathology to
steatohepatitis. Therefore, we next evaluated leukocytes
within the liver. In males, HFD enhances CD64+ cells
with some resolution with chow switch but not with
VSG (Fig. 8a). While CD64+CD11c+ cells increased with
HFD in males (as seen in Fig. 2c), they improved both
with VSG and even more with chow switch. CD64+
CD11c− cells, however, increased with VSG (Fig. 8b, c).
DCs were also expanded with HFD but improved with
VSG and chow switch in males (Fig. 8d). Females failed
to show any significant effects with VSG on liver mac-
rophages (Fig. 8a–d). Imaging studies showed dense
pockets of leukocytes suggesting extramedullary
hematopoiesis in post-VSG animals (Fig. 8f ) that corre-
sponded with increased neutrophils by flow cytometry
in both sexes as demonstrated by lack of significant
two-factor interaction but significant surgery effect
(p < 0.001) (Table 1 and Fig. 8e).
Discussion
Our findings demonstrate that weight loss intervention
strategies have a more profound effect in myeloid in-
flammatory reduction in males than females. This obser-
vation holds true for both dietary-related weight loss
and VSG. It is worth noting that females are protected
from obesity-induced myeloid inflammatory responses
relative to males and overall have a decreased capacity
to elicit a myeloid reduction. Nevertheless, our results
suggest that both weight loss intervention strategies are
more effective in reducing pro-inflammatory myeloid
cell populations in males than females. However, both
the strategies of dietary and surgical interventions to re-
duce obesity failed to completely resolve myeloid inflam-
mation in male mice, although inflammation was
lowered more with dietary intervention. This is crucial
because it shows that dietary strategies should be con-
sidered in addition to surgical intervention alone, in
males. It also suggests that some of the benefits attrib-
uted to surgery are dependent on an improved dietary
intake after surgery. When utilized independently, both
intervention strategies should be considered only
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semi-effective strategies in reducing myeloid cell popula-
tions in males, although metabolism is improved.
Surprisingly, there was a higher level of CD11c− ATMs
with VSG in GWAT of both sexes although CD11c+
ATMs improved (Fig. 6). Ly6Ghi neutrophil populations
were exacerbated by VSG and may likely be correlated
with an increase in splenic mass and extramedullary
hematopoiesis in both sexes (Fig. 5g). CD11c+ popula-
tions, which have been highly implicated in metabolic
disease, are affected differentially by intervention strat-
egy. It is possible that the type of weight loss has a sig-
nificant difference in metabolic disease, with standard
dietary weight loss improving myeloid inflammation
compared to VSG/surgical weight loss due to the slower
nature of weight loss with diet versus surgery. Also, all
animals in the surgical groups with either sham or VSG
surgery had generally lower weights and lower ATM
content than just WL experiments. This could be due to
recovery from a surgery or from expansion of another
population of SVF cells (leukocytes or pre-adipocytes)
that was not measured in these experiments.
Weight loss programs are primarily undertaken in
women, but the impact on inflammation and metabol-
ism is more significant in males since weight loss by
both dietary and surgical interventions reduced meta-
bolic impairment and inflammation more in males. Clin-
ically, it has been found that males and females have
different metabolic responses to low energy diet, with
men having greater reductions in metabolic syndrome Z
score, C-peptide, fat mass, and heart rate, while females
had greater reductions in HDL cholesterol, blood pres-
sure, and hip circumference [26]. Animal studies have
A B C
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Fig. 5 VSG improves body composition but less than switch to standard chow. Six-week-old C57Bl/6j males and females were fed HFD for 12
weeks. At that time, animals underwent sham surgery or vertical sleeve gastrectomy (VSG). Sham animals were either switched to chow or
remained on HFD for an additional 8 weeks. At 26 weeks of age, animals were sacrificed and a total weight, b GWAT weight, and c IWAT weight
recorded. d GWAT H&E slides were imaged (e) and adipocyte sizing was performed. f Liver and g spleen weights were also recorded. *p < 0.05,
***p < 0.005, ****p < 0.001. #p < 0.05, significant differences are shown only between sham chow and VSG chow or sham HFD or VSG HFD N = 6–
9 for VSG chow groups, N = 7–11 for adipocyte sizing, and N = 13–18 for all other data per group
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previously demonstrated that in males, weight loss spe-
cifically leads to improved metabolism; however, inflam-
mation persists due to local macrophage proliferation
[11]. Mechanistically, this is thought to be due to en-
hanced lipolysis promoting proliferation of immune cells
[27]. Although female animals also have significant adi-
posity, improvements yet fail to generate inflammation
with standard weight loss suggesting that there is a sex
difference in response to this type of slow lipolysis. One
possibility is that females have greater capability to store
A B
C
F
E
D
Fig. 6 VSG improves CD11c+ adipose macrophages but CD11c− ATMs do not fully recover in both sexes. Six-week-old C57Bl/6j males and
females were fed HFD for 12 weeks. At that time, animals underwent sham surgery or vertical sleeve gastrectomy (VSG). Sham animals were
either switched to chow or remained on HFD for an additional 8 weeks. At 26 weeks of age, animals were sacrificed and GWAT stromal vascular
fraction (SVF) was isolated and flow cytometry used to quantitate a ATMs, b CD11c− ATMs, c CD11c+ ATMs, d dendritic cells (DC), and e
neutrophils (Ly6G+ cells). f Immunofluorescence performed with caveolin (green) and Mac2 (purple) staining. Inset demonstrating areas of
clustered macrophages seen in male VSG samples. *p < 0.05, ***p < 0.005, ****p < 0.001, significant differences are shown only between sham
chow and VSG chow or sham HFD or VSG HFD. N = 6–9 for VSG chow groups, N = 13–18 for ATM and DC populations, and N = 5–10 for
adipose neutrophils
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adipose tissue and therefore a lesser requirement to gen-
erate ATMs that are important for clearance of fatty acids
and lipids. Also, female ATMs may have a greater potential
for beta oxidation not requiring pro-inflammatory activa-
tion. Hence, a sex difference in weight loss mediated
lipolytic response and lipid metabolism may contribute to
sex differences in inflammation. Interestingly, recent studies
performed in rats have shown a similar increased inflam-
matory phenotype in female livers post-VSG associated
with worsened hepatic triglycerides [28]. The findings of
A B
E
DC
Fig. 7 VSG improves IWAT CD11c+ ATMs and DCs. Six-week-old C57Bl/6J males and females were fed HFD for 12 weeks. At that time, animals
underwent sham surgery or vertical sleeve gastrectomy (VSG). Sham animals were either switched to chow or remained on HFD for an additional
8 weeks. At 26 weeks of age, animals were sacrificed and IWAT stromal vascular fraction (SVF) was isolated and flow cytometry used to quantitate
a ATMs, b CD11c− ATMs, c CD11c+ ATMs, and d dendritic cells (DC). e Myeloid leukocyte subtypes profiled in ovariectomized female mice. *p <
0.05, **p < 0.01, ****p < 0.001. N = 9–18
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Fig. 8 VSG increases liver myeloid cells in both sexes. Six-week-old C57Bl/6J males and females were fed HFD for 12 weeks. At that time, animals
underwent sham surgery or vertical sleeve gastrectomy (VSG). Sham animals were either switched to chow or remained on HFD for an additional
8 weeks. At 26 weeks of age, animals were sacrificed and liver stromal vascular fraction (SVF) was isolated and flow cytometry used to quantitate
a macrophages, b CD11c− macrophages, c CD11c+ macrophages, d dendritic cells (DC), and e neutrophils (Ly6G+ cells). f Liver, a H&E
demonstrating areas of extramedullary hematopoiesis. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001, significant differences are shown only
between sham chow and VSG chow or sham HFD or VSG HFD. N = 6–9 for VSG chow groups, N = 13–18 for macrophages and DC populations
and N = 5–10 for neutrophils
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extramedullary hematopoiesis and likely myeloid progenitor
increases even after weight loss and BMT are likely mecha-
nisms causing such persistent inflammation in WL even in
a clinical setting.
Unlike standard WL, during VSG, both sexes exhibit
some splenomegaly and myeloid inflammation increases
with neutrophils in the GWAT and myeloid cells in the
liver. This suggests that with acute lipolysis, both sexes are
primed to produce inflammation to respond to the rapid
weight loss, but the response is greater in male animals.
Previously, similar systemic inflammatory responses were
demonstrated in male animals [12]. While our finding in
females is unexpected, it is a clinically relevant result since
nearly 80% of bariatric surgery patients are females [14]
and success in weight reduction and T2DM resolution has
been observed 5 years after VSG in predominantly female
cohorts [29]. However, it is critical to continue to monitor
risk for meta-inflammation and its cardiovascular and
metabolic consequences in females [30].
Men have been shown to have increased morbidity
and resource utilization post-bariatric surgery [31], and
our findings of persistent inflammation in male mice
may explain some of this result. One limitation of our
study is the identification of the key factors that promote
the systemic inflammatory response post-VSG. We did
observe that these factors are related to the VSG surgery
itself, and not related to a foreign body response, using a
staple sham group (not shown). There are many possible
lipid mediators, inflammatory mediators, and altered
hormones that are likely be responsible, but given sys-
temic hematopoiesis, it is possible that there are factors
systemically released that drive myelopoiesis or that
prompt the need for inflammatory leukocytes. Specific-
ally, free fatty acids may directly stimulate ATM prolifer-
ation [27, 32]. However, this release from tissues was not
specifically measured in these studies but many lipid
mediators are known to trigger both ATM proliferation
and hematopoiesis [32, 33]. Additionally, given that
there is significant adipose remodeling and there are
likely hematopoietic progenitors within adipose tissue, it
may be this reservoir that remains activated in males
even post-weight loss [34]. Another limitation of our
findings is that female animals did not have significant
obesity although they gain weight with HFD challenge.
It is possible that this is due to the use of the C57Bl/
6J strain which is commonly used in obesity but does
not have the same obesity induction in females as other
strains such as DBA/2J and C3H/HeJ. However, these
two strains do not have as robust of an inflammatory re-
sponse. Future studies in multiple strains with both
sexes are necessary to understand the generalizability of
these results.
A unique aspect of our studies is the evaluation of
tissue-specific leukocytes in both VSG and standard
dietary WL. Clinical studies using RNASeq of adipose
tissue have shown improved inflammatory markers after
VSG [35], but a major limitation of these studies is that
they were performed only in females. However, in these
studies, there are some persistent inflammatory signals
of interferon signaling pathways suggesting that some
tissue remodeling continues post dietary weight loss [36]
and VSG especially in those with higher insulin resist-
ance [37, 38]. The ATM profile changes we see in our
study hence have a similar phenotype to the clinical
models of weight loss. A limitation to our study is that
sometimes as obese men and women undertake lifestyle
changes, they also increase physical activity. It is possible
that if individuals were to further alter their lifestyle with
diet and exercise, they may extend the improvement in
inflammation compared to surgery or dietary-induced
weight loss alone. Exercise independently reduces in-
flammation with more M2 macrophages and reduced
total myeloid in adipose tissue [39] and liver [40]. Fur-
ther investigations into the effects of combined weight
loss strategies are necessary to optimize the metabo-in-
flammatory responses to weight loss.
Overall, these results emphasize that sex differences in
inflammatory responses to high-fat diet and weight loss
make it critical to track prior weight history when coun-
seling on metabolic and cardiovascular risk factors in
the formerly obese individual. These results also suggest
the importance of evaluating inflammation prior to and
after weight loss interventions particularly in men. While
we have not identified all the factors that need to be
considered with weight loss intervention, we have shown
that factors such as the method of weight loss, gender,
and disease risks are important when caring for previ-
ously obese patients and when monitoring for any in-
flammation related conditions.
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